Abstract
To better understand the role of integrin subunit alpha 9 (ITGA9) gene polymorphism in epithelial ovarian cancer (EOC), we investigated the distribution of ITGA9 gene polymorphisms (rs2212020 and rs189897) and revealed whether these polymorphisms were associated with a curative effect in EOC. It was found that rs2212020 and rs189897 were correlated significantly with EOC incidence. The frequency of the C allele of rs2212020 was significantly higher in EOC patients than in the control group (\(P=0.009\), \(\upchi ^{2}=6.857\)). The population with the C allele of rs2212020 had a higher EOC risk than the population with the T allele (\(\hbox {hazard ratio}=1.97\), 95.0% \(\hbox {CI} =1.178-3.299\)). Further, our results showed that the CC genotype was a risk factor for EOC. Regarding the association between ITGA9 and the sensitivity to platinum-based chemotherapy in EOC, there were no statistically significant differences in the frequencies of the rs189897 and rs2212020 polymorphisms between the chemosensitive group and the control group. In multivariate analysis, the patients with the TT genotype of rs189897 had longer progression-free survival (PFS) than the patients without this genotype (\(P=0.010\), \(\hbox {OR}=2.491\)). The AT genotype of rs189897 was a risk factor for PFS in EOC. These findings suggested that rs189897 and rs2212020 could play important roles in EOC diagnosis and prognosis.
Similar content being viewed by others
References
Barrett J. C., Fry B., Maller J. and Daly M. J. 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.
Covens A., Carey M., Bryson P., Verma S., Fung Kee Fung M. and Johnston M. 2002 Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer. Gynecol. Oncol. 85, 71–80.
Cuneo M. G., Schrepf A., Slavich G. M., Thaker P. H., Goodheart M., Bender D. et al. 2017 Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer. Psychoneuroendocrinology 84, 139–142.
Dmitriev A. A., Kashuba V. I., Haraldson K., Senchenko V. N., Pavlova T. V., Kudryavtseva A. V. et al. 2012 Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics 7, 502–513.
Dmitriev A. A., Rosenberg E. E., Krasnov G. S., Gerashchenko G. V., Gordiyuk V. V., Pavlova T. V. et al. 2015 Identification of novel epigenetic markers of prostate cancer by NotI-microarray analysis. Dis. Markers 2015, 241301.
Dong X., Men X., Zhang W. and Lei P. 2014 Advances in tumor markers of ovarian cancer for early diagnosis. Indian J. Cancer 51, e72–e76.
Gerashchenko G. V., Gordiyuk V. V., Skrypkina I. Y., Kvasha S. M., Kolesnik O. O., Ugryn D. D. et al. 2009 Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer. Ukr. Biokhim. Zh. 81, 81–87.
Guichet P. O., Guelfi S., Teigell M., Hoppe L., Bakalara N., Bauchet L. et al. 2015 Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells. Stem Cells 33, 21–34.
Guo W. and Giancotti F. G. 2004 Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816–826.
Jessmon P., Boulanger T., Zhou W. and Patwardhan P. 2017 Epidemiology and treatment patterns of epithelial ovarian cancer. Expert Rev. Anticancer Ther. 17, 427–437.
Junzo K. 2013 New strategy for overcoming resistance to chemotherapy of ovarian cancer. Yonago Acta Med. 56, 43–50.
Kashuba V., Dmitriev A. A., Krasnov G. S., Pavlova T., Ignatjev I., Gordiyuk V. V. et al. 2012 NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer. Int. J. Mol. Sci. 13, 13352–13377.
Li X. M., Li J., Zeng F. and Yi H. 2011 Association of ITGA9 gene rs189897 and rs2212020 genotypes and its haplotype with cerebral infarction (article in Chinese). Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 31, 1142–1145.
Lo K. W., Teo P. M., Hui A. B., To K. F., Tsang Y. S., Chan S. Y. et al. 2000 High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res. 60, 3348–3353.
May T., Comeau R., Sun P., Kotsopoulos J., Narod S. A., Rosen B. et al. 2017 A comparison of survival outcomes in advanced serous ovarian cancer patients treated with primary debulking surgery versus neoadjuvant chemotherapy. Int. J. Gynecol. Cancer 27, 668–674.
Mostovich L. A., Prudnikova T. Y., Kondratov A. G., Loginova D., Vavilov P. V., Rykova V. I. et al. 2011 Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. Cell Adh Migr. 5, 395–401.
Nawaz I., Hu L. F., Du Z. M., Moumad K., Ignatyev I., Pavlova T. V. et al. 2015 Integrin \(\upalpha \)9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. Oncotarget 6, 31493–31507.
Ng C. C., Yew P. Y., Puah S. M., Krishnan G., Yap L. F., Teo S. H. et al. 2009 A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J. Hum. Genet. 54, 392–397.
Ortega P., Moran A., Fernandez-Marcelo T., De Juan C., Frias C., Lopez-Asenjo J. A. et al. 2010 MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. Int. J. Oncol. 36, 1209–1215.
Park H. K., Ruterbusch J. J. and Cote M. L. 2017 Recent trends in ovarian cancer incidence and relative survival in the U.S. by race/ethnicity and histologic subtypes. Cancer Epidemiol. Biomarkers Prev. 26, 1511–1518.
Pastuszak-Lewandoska D., Kordiak J., Antczak A., Migdalska-Sęk M., Czarnecka K. H., Górski P. et al. 2016 Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer. Med. Oncol. 33, 75.
Pavlova T. V., Kashuba V. I., Muravenko O. V., Yenamandra S. P., Ivanova T. A., Zabarovskaia V. I. et al. 2009 Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome. Mol. Biol. (Mosk). 43, 339–347.
Senchenko V. N., Kisseljova N. P., Ivanova T. A., Dmitriev A. A., Krasnov G. S., Kudryavtseva A. V. et al. 2013 Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer. Epigenetics 8, 409–420.
Sherry S. T., Ward M. H., Kholodov M., Baker J., Phan L., Smigielski E. M. and Sirotkin K. 2001 dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311.
Shi Y. Y. and He L. 2005 SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97–98.
Takada Y., Ye X. and Simon S. 2007 The integrins. Genome Biol. 8, 1–9.
Torre L. A., Bray F., Siegel R. L., Ferlay J., Lortet-Tieulent J. and Jemal A. 2011 Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108.
Vozianov S. O., Kashuba V. I., Grygorenko V. M., Gordiyuk V. V., Danylets R. O., Bondarenko Y. M. et al. 2016 Identification of a new diagnostic marker of prostatic cancer, using NotI-microchips [article in Ukrainian]. Klin Khir. 4, 54–57.
Xiong W., Zeng Z. Y., Xia J. H., Xia K., Shen S. R., Li X. L. et al. 2004 A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 64, 1972–1974.
Zagouri F., Dimopoulos M. A., Bournakis E. and Papadimitriou C. A. 2010 Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy. Eur. J. Gynaecol. Oncol. 31, 268–277.
Zhang J., Na S., Liu C., Pan S., Cai J. and Qiu J. 2016 MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma. Tumour Biol. 37, 5941–5949.
Acknowledgements
This work was supported by National Natural Sciences Foundation of China (81672685, 81272975); the Key Planned Science and Technology Project of Hunan Province (2012FJ3084); the Planned Project of Department of Health of Hunan Province (B2011-030, B2012-029); the Natural Science Foundation of Xinjiang Autonomous Region (2017D01C122).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Corresponding editor: H. A. Ranganath
Rights and permissions
About this article
Cite this article
Liu, J., Liu, T., Liang, L. et al. Clinical relationships between the rs2212020 and rs189897 polymorphisms of the ITGA9 gene and epithelial ovarian cancer. J Genet 98, 28 (2019). https://doi.org/10.1007/s12041-019-1078-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-019-1078-1